Belogent, cream 30 g

Belogent has anti-inflammatory, antiallergic, antiproliferative and antipruritic effects.

Betamethasone has anti-inflammatory, antiallergic, antiproliferative and antipruritic effects. When applied to the skin surface, it has fast and strong action in the area of inflammation reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

Gentamicin has broad-spectrum antibacterial (bactericidal) action against most Gram-positive and Gram-negative microorganisms, including Streptococcus strains (beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase-positive, coagulase-negative and some strains producing penicillinase), Proteus, E. coli.

Indications

Dermatoses, allergic and inflammatory skin diseases that respond to therapy with topical corticosteroids, the course of which is complicated by a bacterial infection or there is a risk of its occurrence in children over 1 year of age and in adults:

eczema, diffuse neurodermatitis;
dermatitis – atopic, contact (including occupational), allergic, seborrheic;
infected dermatitis that develops as a result of insect bites;
impetigo;
psoriasis;
lichen planus;
phlebotoderma;
anogenital itching.

Pharmacological effect

Belogent has anti-inflammatory, antiallergic, antiproliferative and antipruritic effects.

Betamethasone has anti-inflammatory, antiallergic, antiproliferative and antipruritic effects. When applied to the surface of the skin, it has a quick and strong effect at the site of inflammation, reducing the severity of objective symptoms (erythema, swelling, lichenification) and subjective sensations (itching, irritation, pain).

Gentamicin has a broad-spectrum antibacterial (bactericidal) effect against most gram-positive and gram-negative microorganisms, incl. strains of streptococcus (beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase-positive, coagulase-negative and some strains producing penicillinase), Proteus, Escherichia coli.

Special instructions

The drug is intended for external use only.

Long-term use of the drug on the skin of the face is not recommended, because the development of rosacea, perioral dermatitis and acne is possible.

It should not be used in the eye area, due to the likelihood of the drug getting into the mucous membrane, which can contribute to the development of cataracts, glaucoma, fungal eye infections and exacerbation of herpetic infections.

Some areas of the body (armpits, inguinal folds), where there is a natural occlusion, are more susceptible to the risk of stretch marks, so the use of the drug in these areas should be short-term.

If a fungal infection develops on the skin, additional use of an antifungal agent is necessary.

With long-term continuous use of the drug, especially in children, on large surfaces of the skin, application to skin with compromised integrity, or when used under an occlusive dressing, systemic side effects may develop, but the likelihood of this is extremely low.

Application in pediatrics. Can be used in children, with caution and for a short period of time. The duration of treatment should be as short as possible. The drug should not be used for children under bandages and especially under plasticized diapers, because this enhances the absorption of the drug and increases the risk of side effects.

Impact on the ability to drive vehicles and machinery. Does not affect the ability to drive vehicles and machinery.

Active ingredient

Betamethasone, Gentamicin

Composition

1 g of cream for external use contains:

active ingredients:

betamethasone dipropionate 0.64 mg (0.064%) in terms of betamethasone – 0.5 mg,

gentamicin sulfate (in terms of gentamicin base) 1 mg (0.1%);

excipients:

chlorocresol – 1 mg;

sodium dihydrogen phosphate monohydrate – 3 mg;

phosphoric acid – 0.02 mg;

soft white paraffin – 150 mg;

liquid paraffin – 60 mg;

macrogol cetostearate – 22.5 mg;

cetostearyl alcohol (cetyl alcohol – 60%, stearyl alcohol – 40%);

sodium hydroxide;

water – 1000 mg

Pregnancy

Possibly if the expected effect of therapy exceeds the potential risk to the fetus.

During pregnancy, the use of Belogent should not be prolonged and, if possible, limited to small areas of the skin. During breastfeeding – only according to strict indications, but Belogent should not be applied to the mammary gland before feeding.

Contraindications

hypersensitivity to betamethasone, gentamicin and other components of Belogent;
viral skin infections, skin post-vaccination reactions;
open wounds, trophic ulcers;
acne vulgaris, rosacea;
chicken pox;
skin manifestations of syphilis;
lupus.

Side Effects

They have a weak character.

Rarely (as with the use of other corticosteroids), hypersensitivity reactions (burning, itching, redness), acne-like changes, hypopigmentation, stretch marks, skin atrophy, hypertrichosis, telangiectasia may develop.

If hypersensitivity reactions occur, discontinue therapy and consult a doctor.

Overdose

With long-term continuous use of the drug, especially in children, on large surfaces of the skin, application to skin with compromised integrity, or when used under an occlusive dressing, systemic side effects may develop, but the likelihood of this is extremely low.

Storage conditions

At a temperature not exceeding 25 °C

Shelf life

4 years

Manufacturer

Belupo, medicines and cosmetics d.d., Croatia